刊名:European Journal of Pharmaceutics and Biopharmaceutics
出版年:2017
出版时间:March 2017
年:2017
卷:112
期:Complete
页码:119-131
全文大小:1144 K
卷排序:112
文摘
Hyperglycosylated human IFN-α2 was produced in CHO and HEK cells. CHO-derived IFN showed highly sialylated and branched glycans. HEK-derived IFN displayed smaller and truncated glycans compared to CHO-derived one. Differences in the glycosylation pattern had not a considerable impact on the elimination half-life. Hyperglycosylated IFN produced in HEK was more efficient as an antiproliferative agent in vitro. IFN4NHEK showed a higher in vivo antitumor activity in animal models.